Stocks Health care VALN
NASDAQ · Health careValneva SE (VALN)
Valneva SE reported revenue of €174.7M in fiscal 2025, up 3.0% from a year earlier. It posted a net loss of €115.2M. In fiscal 2025 capital spending exceeded operating cash flow by €57.3M. At December 31, 2025 it held €109.7M in cash against €179.2M of debt. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on March 17, 2026.
Key facts about Valneva SE
- Net worth
- Valneva SE has a market value (market cap) of $558.4M at the latest share price, and shareholders' equity of €106.2M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was €174.7M (+3.0% year on year), with a net loss of €115.2M.
- Cash flow
- In fiscal 2025 operations used €52.9M of cash.
- Latest report
- The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on March 17, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR
What Valneva SE does
Valneva SE is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker VALN.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | €174.7M | -€115.2M | -€0.68 | -€57.3M |
| 2024 | €169.6M | -€12.2M | -€0.08 | -€81.1M |
| 2023 | €153.7M | -€101.4M | -€0.73 | -€217M |
| 2022 | €361.3M | -€143.3M | -€1.24 | -€274.6M |
| 2021 | €348.1M | -€61.4M | -€0.75 | -€15.3M |
| 2021 | €110.3M | -€55.1M | -€0.71 | €118.8M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where VALN ranks in Health care
Latest SEC filings
What Valneva SE has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 6, 2026
- October 15, 2026
- October 8, 2026
- August 14, 2026
- August 13, 2026
- July 22, 2026
- June 25, 2026
- June 5, 2026
- June 4, 2026Form F-3 filing F-3
- June 1, 2026
Insider trades
What the people running Valneva SE did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
Who owns VALN
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Caisse des depots et consignations13D, may seek influence with 4 related filers | 9.3% | May 12, 2026 |
| Caisse des dépôts et consignations13D, may seek influence with 4 related filers | 8.6% | September 20, 2024 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 20 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Frazier Life Sciences Management, L.P. | 2,291,666 | 0 |
| Vivo Capital, LLC | 763,199 | new |
| General American Investors Co Inc | 354,361 | 0 |
| Millennium Management LLC | 135,223 | new |
| Wells Fargo & Company | 77,214 | -815 |
| Morgan Stanley | 56,217 | +9,292 |
| Ironwood Investment Management LLC | 45,064 | +19,929 |
| Citadel Advisors LLC | 20,294 | new |
| XTX Topco Ltd | 15,178 | new |
| VSM Wealth Advisory, LLC | 10,000 | 0 |
| UBS Group AG | 4,525 | +3,743 |
| GAMMA Investing LLC | 4,089 | +2,663 |
| Rhumbline Advisers | 1,860 | +67 |
| Steigerwald, Gordon & Koch Inc. | 1,250 | 0 |
| Bnp Paribas Financial Markets | 559 | +359 |
| Larson Financial Group LLC | 375 | new |
| Osaic Holdings, Inc. | 90 | +35 |
| Smartleaf Asset Management LLC | 43 | 0 |
| Caitong International Asset Management Co., Ltd | 18 | new |
| Activest Wealth Management | 1 | 0 |
Insiders
Questions about VALN
What does Valneva SE do?
Valneva SE is a company in the Health care sector, listed on NASDAQ as VALN. Its shares trade on NASDAQ under the ticker VALN.
What is Valneva SE's net worth?
Valneva SE has a market value (market cap) of $558.4M at the latest share price, and shareholders' equity of €106.2M on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Valneva SE profitable?
No. In fiscal 2025 it reported a net loss of €115.2M on revenue of €174.7M.
How much revenue does Valneva SE make?
In fiscal 2025 Valneva SE reported revenue of €174.7M. That is 3.0% more than a year earlier.
When did Valneva SE last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on March 17, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from November 6, 2026.
Similar companies
Compare VALN with
Follow VALN
Get an email when Valneva SE files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Valneva SE tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.